does tirzepatide compound work Raleigh, N.C Tirzepatide Injection | Starts at

Mechanism of Action Tirzepatide acts by activating both: GIP receptors GLP-1 receptors This dual incretin activity helps to: Increase glucose-dependent insulin secretion Reduce glucagon secretion during hyperglycemia Delay gastric emptying Increase satiety and reduce caloric intake Promote clinically meaningful weight loss Improve insulin sensitivity indirectly through weight reduction Clinical Benefits When used as prescribed alongside lifestyle modification, MOUNJARO may help: Improve HbA1c levels Lower fasting and post-meal blood glucose Promote substantial body weight reduction Improve insulin sensitivity Reduce appetite and food intake Support long-term glycemic control Improve several cardiometabolic risk factors through weight reduction Clinical benefits vary among individuals

doi: 10.1016/j.jhep.2015.11.004 127 LeoniSTovoliFNapoliLSerioIFerriSBolondiL

Slide the needle guard over the needle until the needle is completely covered (see Figure 6)

Lilly PACKAGE LABEL - Zepbound Multi-Dose Vial - 12.5 mg/0.6 mL Dose (50 mg/2.4 mL [20.8 mg/mL]) Rx Only NDC 0002-6523-11 Zepbound (tirzepatide) injection 50 mg/2.4 mL (20.8 mg/mL) ATTENTION: Contains 4 doses of 12.5 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient